Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ReShape Lifesciences Inc. (OBLN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/05/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Form of Placement Agent Warrant (filed herewith)",
"ReShape Lifesciences Announces Pricing of $3.0 Million Public Offering"
08/07/2023 8-K Quarterly results
04/26/2023 8-K Quarterly results
04/13/2023 8-K Quarterly results
03/21/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
02/10/2023 8-K Quarterly results
01/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BUSINESS Our Company ReShape Lifesciences Inc. is a worldwide premier weight-loss solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. Our current portfolio includes the FDA-approved Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive and extreme surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The recently launched ReShapeCare TM virtual health coaching program is a novel reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients, not just the Lap-Band, further expanding our reach and market opportunity. The ReShape Mar...",
"RISK FACTORS"
12/28/2022 8-K Quarterly results
12/20/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cause",
"Re: Retention Bonus",
"ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer"
07/25/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
04/14/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
03/28/2022 8-K Quarterly results
03/17/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
11/12/2021 8-K Quarterly results
08/16/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
07/19/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "COMMON STOCK PURCHASE WARRANT",
"Number of Exchange Warrants Black Scholes Value of Exchange Warrants DWAC Instructions for Delivery of New Common Shares Number of New Warrants Instructions for Delivery of New Warrants"
06/15/2021 8-K Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Departure of Direct...
Docs: "CERTIFICATE OF THIRD AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION OF OBALON THERAPEUTICS, INC. Obalon Therapeutics, Inc. , a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware , does hereby certify that: A. The name of this corporation is Obalon Therapeutics, Inc. and the date on which the Restated Certificate of Incorporation of this corporation was originally filed with the Secretary of State of the State of Delaware was October 12, 2016 . B. The date on which the first amendment to the Restated Certificate of Incorporation was originally filed with the Secretary of State of the State of Delaware was June 14, 2018. C. The date on which the second amendment to the Restated Certificate of Incorporation was originally fil...",
"CERTIFICATE OF FOURTH AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION OF OBALON THERAPEUTICS, INC.",
"OBALON THERAPEUTICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C CONVERTIBLE PREFERRED STOCK"
06/15/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger"
05/26/2021 8-K Quarterly results
05/21/2021 8-K Quarterly results
05/18/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
03/12/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy